Beam Therapeutics Inc. - COMMON STOCK (BEAM)

CUSIP: 07373V105

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
100,548,635
Total 13F shares
49,225,196
Share change
+3,689,683
Total reported value
$2,820,671,022
Put/Call ratio
119%
Price per share
$57.30
Number of holders
230
Value change
+$201,996,007
Number of buys
136
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 07373V105?
CUSIP 07373V105 identifies BEAM - Beam Therapeutics Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q1 2022

As of 31 Mar 2022, Beam Therapeutics Inc. - COMMON STOCK (BEAM) was held by 230 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,225,196 shares. The largest 10 holders included ARK Investment Management LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Temasek Holdings (Private) Ltd, FARALLON CAPITAL MANAGEMENT LLC, MWG Management Ltd., STATE STREET CORP, Redmile Group, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 230 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.